Company / Book Value per Share
ImmunityBio, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.587
FY2025
5-year range
-$1.392 / -$0.587
FY2021-FY2025
Trend
+19.5%
vs FY2024
Sector context
#196 of 209
Health Care
What the data says
Among 209 Health Care companies, ImmunityBio, Inc. is in the bottom 6% for book value per share. Book Value per Share has fluctuated over the past 10 years, ranging from -$1.392 in FY2023 to $4.342 in FY2017.
Based on SEC 10-K filings.
-$0.587 in FY2025.
Improved from -$1.392 to -$0.587 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 209This company -$0.587 Sector average $215.686
▼
-100.3% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 19.5% year-over-year.
- Ranks #196 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2017.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.587 | +19.5% |
| FY2024 | -$0.729 | +47.6% |
| FY2023 | -$1.392 | -23.8% |
| FY2022 | -$1.124 | -77.5% |
| FY2021 | -$0.634 | +47.9% |
| FY2020 | -$1.217 | -179.7% |
| FY2019 | $1.526 | -58.9% |
| FY2018 | $3.713 | -14.5% |
| FY2017 | $4.342 | +513.1% |
| FY2016 | $0.708 | -99.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026